Aigh Capital Management LLC Ani Pharmaceuticals Inc Transaction History

Aigh Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$50.28 - $64.61 $3.9 Million - $5.01 Million	-77,524 Reduced 22.13%	272,801 $15.8 Million
Q2 2023 Aug 14, 2023	BUY	$37.29 - $53.83 $82,746 - $119,448	2,219 Added 0.64%	350,325 $18.9 Million
Q1 2023 May 15, 2023	SELL	$37.61 - $45.72 $376,100 - $457,200	-10,000 Reduced 2.79%	348,106 $13.8 Million
Q4 2022 Feb 14, 2023	BUY	$31.9 - $41.95 $1.39 Million - $1.83 Million	43,700 Added 13.9%	358,106 $14.4 Million
Q3 2022 Nov 10, 2022	BUY	$29.83 - $38.01 $2.09 Million - $2.66 Million	69,906 Added 28.59%	314,406 $10.1 Million
Q2 2022 Aug 12, 2022	BUY	$23.09 - $33.46 $5.65 Million - $8.18 Million	244,500 New	244,500 $7.25 Million

213

18.6M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.02B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Aigh Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aigh Capital Management LLC with notifications on news.